DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20221468

Dilated cardiomyopathy and pregnancy outcome: a case report

Kanili Jimo, Avitso Liegise, Adahru Moses, Bendangtoshi Jamir, Rebeki Momin, Vivek Thapa

Abstract


Cardiomyopathy is a group of diseases that affect the heart muscle. Dilated cardiomyopathy, a form of cardiomyopathy, is characterised by ventricular chamber enlargement and contractile dysfunction, and has recurrences in subsequent pregnancies. Pregnancy by itself is associated with significant hemodynamic burden and cardiovascular changes, which when coupled with dilated cardiomyopathy results in increased morbidity and mortality in both mother and child. Management of such a condition presents serious therapeutic challenge to a multidisciplinary team. Here, we report a case of a 36-year-old woman primigravida with gestational age of 11 weeks, known case of dilated cardiomyopathy. Despite the risks and associated complications with the disease, she continued her pregnancy. Patient was managed by a team of obstetrician, cardiologist and anaesthesiologist and underwent caesarean section giving birth to a live baby. The aim of this article is to provide guidance on how to manage a patient with dilated cardiomyopathy throughout her pregnancy. Early diagnosis of heart disease, regular antenatal check-ups, institutional delivery and multidisciplinary approach can reduce the maternal and perinatal morbidity and mortality.

 


Keywords


Pregnancy, Heart disease, Dilated cardiomyopathy, Caesarean section

Full Text:

PDF

References


Nanna M, Stergiopoulos K. Pregnancy Complicated by Valvular Heart Disease: an Update. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2014;3(3):e000712.

Pritchard JA. Changes in the blood volume during pregnancy and delivery. Anesthesiology. 1965;26:393-9.

Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006;92:1520-5.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165-241.

Grewal J, Siu SC, Ross HJ. Pregnancy Outcomes in Women With Dilated Cardiomyopathy. J Am Coll Cardiol. 2010;55:45-52.

Katsuragi S, Omoto A, Kamiya C. Risk factors for maternal outcome in pregnancy complicated with dilated cardiomyopathy. J Perinatol. 2012;32:170-5.

Kannan M, Vijayanand G. Mitral stenosis and pregnancy: Current concepts in anaesthetic practice. Indian J Anaesth. 2010;54:439-44.

Bonow RO, Carabello BA, Chatterjee K, de Leon Jr AC, Faxon DP, Freed MD, et al. Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the management of patients with valvular heart disease: a report of the Ameri¬can College of Cardiology/American Heart Asso¬ciation Task Force on Practice Guidelines (Writ¬ing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Endorsed by the Society of Cardiovascu¬lar Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(13):e1-142.

Reimold SC, Rutherford JD. Valvular heart disease in pregnancy. N Engl J Med. 2003;349(1):52-9.